Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Change of Meeting Location, 33629 [2010-14153]

Download as PDF Federal Register / Vol. 75, No. 113 / Monday, June 14, 2010 / Notices applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Translational Research Program Grant Review Panel. Date: July 16, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Hotel, Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Daniel R. Kenshalo, PhD, Scientific Review Officer, National Eye Institute, National Institutes of Health, 5635 Fishers Lane, Suite 1300, MSC 9300, 301– 451–2020, kenshalod@nei.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: June 2, 2010. Jennifer Spaeth, Director, Office of Federal Advisory, Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration, individuals interested in presenting to the panelists to register by May 25, 2010. Registration to present at the workshop is closed. All others are welcome to attend on a first-come, firstserved basis. Because of a greater than anticipated response for attending the public workshop, FDA is announcing in this notice a new location. II. New Location for the Public Workshop The new location will be the Holiday Inn College Park (see ADDRESSES). Directions and information on parking, accommodations, and transportation options can be found at www.holidayinncollegepark.com. Dated: June 8, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–14153 Filed 6–11–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HOMELAND SECURITY HHS. ACTION: National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. app.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. emcdonald on DSK2BSOYB1PROD with NOTICES BILLING CODE 4140–01–P AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Center for Scientific Review Special Emphasis Panel Member Conflict: Cancer Molecular Therapy. Date: June 17, 2010. Time: 1:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Syed M Quadri, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301–435– 1211, quadris@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing Jkt 220001 [FR Doc. 2010–14196 Filed 6–11–10; 8:45 am] Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Change of Meeting Location BILLING CODE 4140–01–P 16:40 Jun 11, 2010 Dated: June 7, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [Docket No. FDA–2010–N–0168] [FR Doc. 2010–14193 Filed 6–11–10; 8:45 am] VerDate Mar<15>2010 limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). 33629 Science and Technology (S&T) Directorate Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing a change in location for the upcoming public workshop entitled ‘‘Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors.’’ A new address is given for those attending the workshop. DATES: The public workshop will be held on Thursday and Friday, June 24 and 25, 2010, from 8:30 a.m. to 5 p.m. each day. ADDRESSES: The public workshop will be held at the Holiday Inn College Park, 10000 Baltimore Ave., College Park, MD 20740. FOR FURTHER INFORMATION CONTACT: Colleen O’Malley, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, rm. 4305, Silver Spring, MD 20993–0002, 301– 796–1786, FAX: 301–796–9832, e-mail: colleen.omalley@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of April 12, 2010 (75 FR 18514), FDA issued a notice announcing a public workshop that is intended to assist the agency in developing draft guidance for industry on describing practices for naming, labeling, and packaging drugs and biologics to reduce medication errors. The April 12, 2010, notice invited PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 [Docket No. DHS–2010–0043] Agency Information Collection Activities: Submission for Review; Information Collection Request for the Department of Homeland Security (DHS) Science and Technology Protected Repository for the Defense of Infrastructure against Cyber Threats (PREDICT) Program AGENCY: Science and Technology Directorate, DHS. ACTION: 60-day Notice and request for comment. SUMMARY: The Department of Homeland Security invites the general public to comment on data collection forms for the Protected Repository for the Defense of Infrastructure Against Cyber Threats (PREDICT) initiative. PREDICT is an initiative to facilitate the accessibility of computer and network operational data for use in cybersecurity defensive research and development. Specifically, PREDICT provides developers and evaluators with regularly updated network operations data sources relevant to cybersecurity defense technology development. The data sets are intended to provide developers with timely and detailed insight into cyberattack phenomena occurring across the Internet and in some cases will reveal the effects of these attacks on networks that are owned or managed by E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 75, Number 113 (Monday, June 14, 2010)]
[Notices]
[Page 33629]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-14153]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0168]


Developing Guidance on Naming, Labeling, and Packaging Practices 
to Reduce Medication Errors; Public Workshop; Change of Meeting 
Location

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a change 
in location for the upcoming public workshop entitled ``Developing 
Guidance on Naming, Labeling, and Packaging Practices to Reduce 
Medication Errors.'' A new address is given for those attending the 
workshop.

DATES: The public workshop will be held on Thursday and Friday, June 24 
and 25, 2010, from 8:30 a.m. to 5 p.m. each day.

ADDRESSES: The public workshop will be held at the Holiday Inn College 
Park, 10000 Baltimore Ave., College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Colleen O'Malley, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 22, rm. 4305, Silver Spring, MD 20993-0002, 301-
796-1786, FAX: 301-796-9832, e-mail: colleen.omalley@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of April 12, 2010 (75 FR 18514), FDA issued 
a notice announcing a public workshop that is intended to assist the 
agency in developing draft guidance for industry on describing 
practices for naming, labeling, and packaging drugs and biologics to 
reduce medication errors. The April 12, 2010, notice invited 
individuals interested in presenting to the panelists to register by 
May 25, 2010. Registration to present at the workshop is closed. All 
others are welcome to attend on a first-come, first-served basis.
    Because of a greater than anticipated response for attending the 
public workshop, FDA is announcing in this notice a new location.

II. New Location for the Public Workshop

    The new location will be the Holiday Inn College Park (see 
ADDRESSES). Directions and information on parking, accommodations, and 
transportation options can be found at www.holidayinncollegepark.com.

    Dated: June 8, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-14153 Filed 6-11-10; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.